TRPM2 mediates distruption of autophagy machinery and correlates with the grade level in prostate cancer

dc.contributor.authorTektemur, Ahmet
dc.contributor.authorOzaydin, Seda
dc.contributor.authorOnalan, Ebru Etem
dc.contributor.authorKaya, Nalan
dc.contributor.authorKuloglu, Tuncay
dc.contributor.authorOzercan, Ibrahim Hanifi
dc.contributor.authorElyas, Halit Mohammed
dc.date.accessioned2026-08-12T17:34:02Z
dc.date.issued2019
dc.departmentFırat Üniversitesi
dc.description.abstractPurposeTransient receptor potential melastatin 2 (TRPM2), a calcium-permeable ion channel, is shown as a prognostic marker candidate in prostate cancer (PCa) and an important regulator of autophagy. We aimed to determine the changes in TRPM2 and autophagic-apoptotic gene expression levels in human prostate adenocarcinomas, and to investigate the affect of TRPM2 on autophagic pathways in PC-3 cell line.MethodsHuman prostate tissues were classified considering the grade levels and were divided into the control, BPH, and grade 1-5 groups. mRNA expression levels of genes were determined by qPCR. In addition, TRPM2 was evaluated immunohistochemically for each group. In PC-3 cell line, TRPM2 was silenced through siRNA transfection, and autophagy induction was analyzed by acridine orange (AO) staining.ResultsThe qPCR and immunoreactivity results showed that the increased TRPM2 expression levels in human PCa samples were paralleled with higher grade levels. The autophagic-apoptotic gene expressions showed high variability in different grade levels. Also, silencing TRPM2 in PC-3 cells altered autophagic gene expressions and caused autophagy induction according to the AO staining results.ConclusionWe showed that the autophagy-TRPM2 association may take place in the molecular basis of PCa and accordingly this connection may be targeted as a new therapeutic approach in PCa.
dc.description.sponsorshipFirat University Scientific Research Projects Unit [TF.14.37]
dc.description.sponsorshipThis project was supported by the Firat University Scientific Research Projects Unit (Project No: TF.14.37).
dc.identifier.doi10.1007/s00432-019-02898-z
dc.identifier.endpage1311
dc.identifier.issn0171-5216
dc.identifier.issn1432-1335
dc.identifier.issue5
dc.identifier.orcid0000-0001-8880-4932
dc.identifier.orcid0000-0002-2757-1802
dc.identifier.orcid0000-0002-2476-0413
dc.identifier.orcid0000-0001-9874-3838
dc.identifier.pmid30888515
dc.identifier.scopus2-s2.0-85063086931
dc.identifier.scopusqualityQ2
dc.identifier.startpage1297
dc.identifier.urihttps://doi.org/10.1007/s00432-019-02898-z
dc.identifier.urihttps://hdl.handle.net/11508/57250
dc.identifier.volume145
dc.identifier.wosWOS:000465605800018
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSpringer
dc.relation.ispartofJournal of Cancer Research and Clinical Oncology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260511
dc.subjectProstate cancer
dc.subjectIon channels
dc.subjectTransient receptor potential melastatin 2 (TRPM2)
dc.subjectAutophagy
dc.subjectGene expression
dc.titleTRPM2 mediates distruption of autophagy machinery and correlates with the grade level in prostate cancer
dc.typeArticle

Dosyalar